Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 22, 2016, Pages 6289-6294

  DiGiuseppe, Stephen ^a   Luszczek, Wioleta ^a   Keiffer, Timothy R ^a   Bienkowska Haba, Malgorzata ^a   Guion, Lucile G M ^a   Sapp, Martin J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Digitonin; Hpv entry; Mitosis; Nuclear vesicle; Vesicular transport

Indexed keywords

CAPSID PROTEIN L2; NUCLEASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CHROMOSOME; CONTROLLED STUDY; FEMALE; FLOTATION; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MICROTUBULE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; STAINING; TRANS GOLGI NETWORK; TRANSPORT VESICLE; VIRUS GENOME; CYTOPLASM VESICLE; ENDOSOME; GENETICS; METABOLISM; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY; PROTEIN TRANSPORT; VIRION; VIROLOGY; VIRUS ENTRY;

CELL NUCLEUS; CYTOPLASMIC VESICLES; ENDOSOMES; GENOME, VIRAL; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MITOSIS; PAPILLOMAVIRUS INFECTIONS; PROTEIN TRANSPORT; TRANS-GOLGI NETWORK; VIRION; VIRUS INTERNALIZATION;

EID: 84971505107     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1600638113     Document Type: Article

References (57)

1. Paludan SR, Bowie AG (2013) Immune sensing of DNA. Immunity 38(5):870-880.
2. Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M (2012) Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol 86(18):9875-9887.
3. Buck CB, et al. (2008) Arrangement of L2 within the papillomavirus capsid. J Virol 82(11):5190-5197.
4. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2005) Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med 119: 445-462.
5. Modis Y, Trus BL, Harrison SC (2002) Atomic model of the papillomavirus capsid. EMBO J 21(18):4754-4762.
6. Klug A, Finch JT (1965) Structure of viruses of the papilloma-polyoma type, I: Human wart virus. J Mol Biol 11:403-423.
7. Knappe M, et al. (2007) Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem 282(38): 27913-27922.
8. Giroglou T, Florin L, Schäfer F, Streeck RE, Sapp M (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75(3):1565-1570.
9. Joyce JG, et al. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274(9):5810-5822.
10. Selinka HC, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81(20):10970-10980.
11. Culp TD, Budgeon LR, Christensen ND (2006) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347(1):147-159.
12. Richards KF, Bienkowska-Haba M, Dasgupta J, Chen XS, Sapp M (2013) Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol 87(21):11426-11437.
13. Day PM, Schiller JT (2009) The role of furin in papillomavirus infection. Future Microbiol 4(10):1255-1262.
14. Richards RM, Lowy DR, Schiller JT, Day PM (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 103(5):1522-1527.
15. Schelhaas M, et al. (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog 8(4):e1002657.
16. Spoden G, et al. (2008) Clathrin- and caveolin-independent entry of human papillomavirus type 16: Involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3(10):e3313.
17. Scheffer KD, Berditchevski F, Florin L (2014) The tetraspanin CD151 in papillomavirus infection. Viruses 6(2):893-908.
18. Scheffer KD, et al. (2013) Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol 87(6):3435-3446.
19. Abban CY, Meneses PI (2010) Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology 403(1):1-16.
20. Yoon CS, Kim KD, Park SN, Cheong SW (2001) alpha(6) integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 283(3):668-673.
21. Evander M, et al. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71(3):2449-2456.
22. Surviladze Z, Dziduszko A, Ozbun MA (2012) Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 8(2):e1002519.
23. DiGiuseppe S, Bienkowska-Haba M, Hilbig L, Sapp M (2014) The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network. Virology 458-459:93-105.
24. Bienkowska-Haba M, Patel HD, Sapp M (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5(7):e1000524.
25. Bergant M, Banks L (2013) SNX17 facilitates infection with diverse papillomavirus types. J Virol 87(2):1270-1273.
26. Bergant Maruš ič M, Ozbun MA, Campos SK, Myers MP, Banks L (2012) Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic 13(3):455-467.
27. Lipovsky A, et al. (2013) Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci USA 110(18): 7452-7457.
28. Popa A, et al. (2015) Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PLoS Pathog 11(2):e1004699.
29. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT (2013) Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol 87(7):3862-3870.
30. Florin L, et al. (2006) Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol 80(13):6691-6696.
31. Schneider MA, Spoden GA, Florin L, Lambert C (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13(1):32-46.
32. DiGiuseppe S, et al. (2015) Topography of the human papillomavirus minor capsid protein l2 during vesicular trafficking of infectious entry. J Virol 89(20):10442-10452.
33. Zhang W, Kazakov T, Popa A, DiMaio D (2014) Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ -secretase activity. MBio 5(5):e01777-e14.
34. Aydin I, et al. (2014) Large-scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog 10(5): e1004162.
35. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5(2):e1000318.
36. Cubie HA (2013) Diseases associated with human papillomavirus infection. Virology 445(1-2):21-34.
37. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78(2):751-757.
38. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005) Maturation of papillomavirus capsids. J Virol 79(5):2839-2846.
39. Lee JH, et al. (2004) Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci USA 101(7):2094-2099.
40. Ishii Y, et al. (2010) Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. Virology 406(2):181-188.
41. Engel S, et al. (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85(9):4198-4211.
42. Selinka HC, Giroglou T, Sapp M (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299(2):279-287.
43. Moss B (2006) Poxvirus entry and membrane fusion. Virology 344(1):48-54.
44. Liu M, et al. (2006) Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells. J Biol Chem 281(26):18090-18097.
45. Bayer N, et al. (1998) Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: Implications for viral uncoating and infection. J Virol 72(12):9645-9655.
46. Hernandez-Verdun D (2011) Assembly and disassembly of the nucleolus during the cell cycle. Nucleus 2(3):189-194.
47. Muro E, et al. (2010) The traffic of proteins between nucleolar organizer regions and prenucleolar bodies governs the assembly of the nucleolus at exit of mitosis. Nucleus 1(2):202-211.
48. Mamoor S, et al. (2012) The high-risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology 422(2):413-424.
49. Shima DT, Haldar K, Pepperkok R, Watson R, Warren G (1997) Partitioning of the Golgi apparatus during mitosis in living HeLa cells. J Cell Biol 137(6):1211-1228.
50. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79(4):1992-2000.
51. Inoue T, Tsai B (2011) A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathog 7(5):e1002037.
52. Rainey-Barger EK, Magnuson B, Tsai B (2007) A chaperone-activated nonenveloped virus perforates the physiologically relevant endoplasmic reticulum membrane. J Virol 81(23):12996-13004.
53. Faenza I, Fiume R, Piazzi M, Colantoni A, Cocco L (2013) Nuclear inositide specific phospholipase C signaling: Interactions and activity. FEBS J 280(24):6311-6321.
54. Farr GA, Zhang LG, Tattersall P (2005) Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc Natl Acad Sci USA 102(47):17148-17153.
55. Buck CB, Thompson CD (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chap. 26:Unit 26.1.
56. Leder C, Kleinschmidt JA, Wiethe C, Müller M (2001) Enhancement of capsid gene expression: Preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol 75(19):9201-9209.
57. Kobayashi T, et al. (2002) Separation and characterization of late endosomal membrane domains. J Biol Chem 277(35):32157-32164.